US Markets for Vascular Access Devices 2009

Table of Contents

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US VASCULAR ACCESS DEVICE MARKET

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Key Report Updates
  • 1.2.2 Economic Assumptions for the Forecast Period
  • 1.2.3 Device Overview
  • 1.2.4 Procedures
  • 1.2.5 Market Forecast
    • 1.2.5.1 Antimicrobial - Coated Vascular Access Device Market
  • 1.2.6 Market Drivers and Limiters
• 1.3 Competitive Analysis
  • 1.3.1 Market Shares

2.0 SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Device Overview
  • 2.2.2 Procedures
    • 2.2.2.1 Acute Care Short Peripheral Intravenous Catheter Procedures
    • 2.2.2.2 Alternate Care Short Peripheral Intravenous Catheter Procedures
  • 2.2.3 Market Forecast by Setting
    • 2.2.3.1 Acute Care Short Peripheral Intravenous Catheter Market
    • 2.2.3.2 Alternate Care Short Peripheral Intravenous Catheter Market
  • 2.2.4 Market Forecast by Type
    • 2.2.4.1 Safety Short Peripheral Intravenous Catheter Market
    • 2.2.4.2 Standard Short Peripheral Intravenous Catheter Market
  • 2.2.5 Market Drivers and Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares
  • 2.3.3 Competitor Discussions (in Alphabetical Order)
    • B. Braun Medical
    • Becton Dickinson
    • Smiths Medical
    • Other

3.0 CENTRAL VENOUS CATHETER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Device Overview
  • 3.2.2 Procedures
    • 3.2.2.1 Acute Central Venous Catheter Procedures
    • 3.2.2.2 Tunneled Central Venous Catheter Procedures
  • 3.2.3 Market Forecast
    • 3.2.3.1 Acute Central Venous Catheter Market
    • 3.2.3.2 Tunneled Central Venous Catheter Market
  • 3.2.4 Market Drivers and Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
  • 3.3.2 Market Shares
  • 3.3.3 Competitor Discussions (in Alphabetical Order)
    • Arrow International (a Teleflex Medical company)
    • Cook Medical
    • C. R. Bard
    • Edwards Lifesciences
    • Other

4.0 PERIPHERALLY INSERTED CENTRAL CATHETER MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Device Overview
  • 4.2.2 Procedures
    • 4.2.2.1 Standard Peripherally Inserted Central Catheter Procedures
    • 4.2.2.2 Power - Injectable Peripherally Inserted Central Catheter Procedures
  • 4.2.3 Market Forecast
    • 4.2.3.1 Standard Peripherally Inserted Central Catheter Market
    • 4.2.3.2 Power - Injectable Peripherally Inserted Central Catheter Market
  • 4.2.4 Market Drivers and Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares
  • 4.3.3 Competitor Discussions (in Alphabetical Order)
    • AngioDynamics
    • Arrow International (a Teleflex Medical company)
    • Cook Medical
    • C. R. Bard
    • Navilyst Medical
    • Other

5.0 IMPLANTABLE PORT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Device Overview
  • 5.2.2 Procedures
    • 5.2.2.1 Single - Lumen Implantable Port Procedures
    • 5.2.2.2 Dual - Lumen Implantable Port Procedures
  • 5.2.3 Market Forecast
    • 5.2.3.1 Single - Lumen Implantable Port Market
      • Standard Single - Lumen Implantable Port Market
      • Power - Injectable Single - Lumen Implantable Port Market
      • 5.2.3.2 Dual - Lumen Implantable Port Market
      • Standard Dual - Lumen Implantable Port Market
      • Power - Injectable Dual - Lumen Implantable Port Market
  • 5.2.4 Market Drivers and Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Competitive Landscape
  • 5.3.2 Market Shares
  • 5.3.3 Competitor Discussions (in Alphabetical Order)
    • AngioDynamics
    • C. R. Bard
    • Navilyst Medical
    • Smiths Medical
    • Other

6.0 DIALYSIS CATHETER MARKET

• 6.1 Market Overview
• 6.2 Disease Overview
  • 6.2.1 End - Stage Renal Disease
  • 6.2.2 Treatment of End - Stage Renal Disease
    • 6.2.2.1 Hemodialysis
    • 6.2.2.2 Peritoneal Dialysis
    • 6.2.2.3 Kidney Transplant
• 6.3 Market Analysis
  • 6.3.1 Dialysis Catheter Model Assumptions
  • 6.3.2 Procedures
    • 6.3.2.1 Chronic Dialysis Catheter Procedures
    • 6.3.2.2 Acute Dialysis Catheter Procedures
      • Antimicrobial - Coated Acute Dialysis Catheter Procedures
  • 6.3.3 Market Forecast
    • 6.3.3.1 Chronic Dialysis Catheter Market
    • 6.3.3.2 Acute Dialysis Catheter Market
      • Antimicrobial - Coated Acute Dialysis Catheter Market
  • 6.3.4 Market Drivers and Limiters
• 6.4 Competitive Analysis
  • 6.4.1 Competitive Landscape
  • 6.4.2 Market Shares
  • 6.4.3 Competitor Discussions (in Alphabetical Order)
    • AngioDynamics
    • Arrow International (a Teleflex Medical company)
    • C. R. Bard
    • Navilyst Medical
    • Other

7.0 HUBER NEEDLE MARKET

• 7.1 Market Overview
• 7.2 Market Analysis
  • 7.2.1 Device Overview
  • 7.2.2 Procedures
  • 7.2.3 Market Forecast
  • 7.2.4 Market Drivers and Limiters
• 7.3 Competitive Analysis
  • 7.3.1 Competitive Landscape
  • 7.3.2 Competitor Discussions (in Alphabetical Order)
    • AngioDynamics
    • C. R. Bard
    • Smiths Medical
    • Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL EXHIBITS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit 1: Vascular Access Device Market, US (US$), 2007 - 2013
• Exhibit 2: Vascular Access Device Market, by Type, as a % of Total, US, 2008
• Exhibit 3: Short PIVC Market, by Setting, US (US$), 2007 - 2013
• Exhibit 4: Acute CVC Procedures, by Coating, US, 2007 - 2013
• Exhibit 5: PICC Sales, by Injection Type, US, 2007 - 2013
• Exhibit 6: Implantable Port Procedures, by Lumen Number, US, 2007 - 2013
• Exhibit 7: Chronic Dialysis Catheter Market, US (US$), 2007 - 2013
• Exhibit 8: Huber Needle Sales, by Type, US, 2007 - 2013
• Exhibit 9: Leading Competitors in the Vascular Access Device Market, US, 2008

CHAPTER 1: US VASCULAR ACCESS DEVICE MARKET

• Exhibit 10: Vascular Access Device Market, US, (US$), 2007 - 2013
• Exhibit 11: Key Report Updates, 2009
• Exhibit 12: Vascular Access Device Market, by Type, as a % of Total, US, 2008
• Exhibit 13: Vascular Access Device Implantation Procedures, US, 2007 - 2013
• Exhibit 14: Vascular Access Implantation Procedures, by Device Type, US, 2007 - 2013
• Exhibit 15: Vascular Access Device Market, by Type, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 16: Vascular Access Device Market, by Type, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 17: Antimicrobial Vascular Access Device Market, by Type, US (US$), 2007 - 2013
• Exhibit 18: Drivers of the Vascular Access Device Market, US
• Exhibit 19: Limiters of the Vascular Access Device Market, US
• Exhibit 20: Leading Competitors in the Vascular Access Device Market, as a % of Total, US, 2008
• Exhibit 21: Leading Competitors in the Vascular Access Device Market, by Type, as a % of Total, US, 2008

CHAPTER 2: SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET

• Exhibit 22: Short PIVC Market, US (US$), 2007 - 2013
• Exhibit 23: Short PIVC Procedures, by Setting, US, 2007 - 2013 (Graphical Format)
• Exhibit 24: Short PIVC Procedures, by Setting, US, 2007 - 2013 (Tabular Format)
• Exhibit 25: Short PIVC Market, by Setting, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 26: Short PIVC Market, by Setting, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 27: Short PIVC Market Growth, by Setting, US, 2008 - 2013
• Exhibit 28: Short PIVC Market, by Setting, as a % of Total, US, 2007 - 2013
• Exhibit 29: Acute Care Short PIVC Market, by Type, US, (US$), 2007 - 2013
• Exhibit 30: Acute Care Short PIVC Market Growth, by Type, 2008 - 2013
• Exhibit 31: Acute Care Short PIVC Market, by Type, as a % of Total, 2007 - 2013
• Exhibit 32: Alternate Care Short PIVC Market, by Type, US (US$), 2007 - 2013
• Exhibit 33: Alternate Care Short PIVC Market Growth, by Type, 2008 - 2013
• Exhibit 34: Alternate Care Short PIVC Market, by Type, as a % of Total, 2007 - 2013
• Exhibit 35: Safety Short PIVC Market, by Setting, US (US$), 2007 - 2013
• Exhibit 36: Safety Short PIVC Market Growth, by Setting, US, 2008 - 2013
• Exhibit 37: Safety Short PIVC Market, by Setting, as a % of Total, US, 2007 - 2013
• Exhibit 38: Standard Short PIVC Market, by Setting, US (US$), 2007 - 2013
• Exhibit 39: Standard Short PIVC Market Growth, by Setting, US, 2008 - 2013
• Exhibit 40: Standard Short PIVC Market, by Setting, as a % of Total, US, 2007 - 2013
• Exhibit 41: Drivers of the Short PIVC Market, US
• Exhibit 42: Limiters of the Short PIVC Market, US
• Exhibit 43: Leading Competitors in the Short PIVC Market, by Type, as a % of Total, US, 2008

CHAPTER 3: CENTRAL VENOUS CATHETER MARKET

• Exhibit 44: CVC Market, US (US$), 2007 - 2013
• Exhibit 45: CVC Procedures, by Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 46: CVC Procedures, by Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 47: Acute CVC Procedures, by Coating, US, 2007 - 2013 (Graphical Format)
• Exhibit 48: Acute CVC Procedures, by Coating, US, 2007 - 2013 (Tabular Format)
• Exhibit 49: Tunneled CVC Procedures, US, 2007 - 2013
• Exhibit 50: CVC Market, by Type, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 51: CVC Market, by Type, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 52: CVC Market Growth, by Type, US, 2008 - 2013
• Exhibit 53: CVC Market, by Type, as a % of Total, US, 2007 - 2013
• Exhibit 54: Acute CVC Market, by Coating, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 55: Acute CVC Market, by Coating, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 56: Acute CVC Market Growth, by Coating, US, 2008 - 2013
• Exhibit 57: Acute CVC Market, by Coating, as a % of Total, US, 2007 - 2013
• Exhibit 58: Drivers of the CVC Market, US
• Exhibit 59: Limiters of the CVC Market, US
• Exhibit 60: Leading Competitors in the CVC Market, by Type, as a % of Total, US, 2008

CHAPTER 4: PERIPHERALLY INSERTED CENTRAL CATHETER MARKET

• Exhibit 61: PICC Market, US (US$), 2007 - 2013
• Exhibit 62: PICC Procedures, by Injection Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 63: PICC Procedures, by Injection Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 64: Standard PICC Procedures, by Operator, US, 2007 - 2013 (Graphical Format)
• Exhibit 65: Standard PICC Procedures, by Operator, US, 2007 - 2013 (Tabular Format)
• Exhibit 66: Power - Injectable PICC Procedures, by Operator, US, 2007 - 2013 (Graphical Format)
• Exhibit 67: Power - Injectable PICC Procedures, by Operator, US, 2007 - 2013 (Tabular Format)
• Exhibit 68: PICC Market, by Injection Type, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 69: PICC Market, by Injection Type, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 70: PICC Market Growth, by Injection Type, US, 2008 - 2013
• Exhibit 71: PICC Market, by Injection Type, as a % of Total, US, 2007 - 2013
• Exhibit 72: Standard PICC Market, by Operator, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 73: Standard PICC Market, by Operator, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 74: Standard PICC Market Growth, by Operator, US, 2008 - 2013
• Exhibit 75: Standard PICC Market, by Operator, as a % of Total US, 2007 - 2013
• Exhibit 76: Power - Injectable PICC Market, by Operator, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 77: Power - Injectable PICC Market, by Operator, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 78: Power - Injectable PICC Market Growth, by Operator, US, 2008 - 2013
• Exhibit 79: Power - Injectable PICC Market, by Operator, as a % of Total US, 2007 - 2013
• Exhibit 80: Drivers of the PICC Market, US
• Exhibit 81: Limiters of the PICC Market, US
• Exhibit 82: Leading Competitors in the PICC Market, as a % of Total, US, 2008

CHAPTER 5: IMPLANTABLE PORT MARKET

• Exhibit 83: Implantable Port Market, US (US$), 2007 - 2013
• Exhibit 84: Implantable Port Procedures, by Lumen Number, US, 2007 - 2013 (Graphical Format)
• Exhibit 85: Implantable Port Procedures, by Lumen Number, US, 2007 - 2013 (Tabular Format)
• Exhibit 86: Single - Lumen Implantable Port Procedures, by Injection Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 87: Single - Lumen Implantable Port Procedures, by Injection Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 88: Dual - Lumen Implantable Port Procedures, by Injection Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 89: Dual - Lumen Implantable Port Procedures, by Injection Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 90: Implantable Port Market, by Lumen Number, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 91: Implantable Port Market, by Lumen Number, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 92: Implantable Port Market Growth, by Lumen Number, US, 2008 - 2013
• Exhibit 93: Implantable Port Market, by Lumen Number, as a % of Total, US, 2007 - 2013
• Exhibit 94: Single - Lumen Implantable Port Market, by Injection Type, US (US$), 2007 - 2013
• Exhibit 95: Single - Lumen Implantable Port Market Growth, by Injection Type, US, 2008 - 2013
• Exhibit 96: Single - Lumen Implantable Port Market, by Injection Type, as a % of Total, US, 2007 - 2013
• Exhibit 97: Dual - Lumen Implantable Port Market, by Injection Type, US (US$), 2007 - 2013
• Exhibit 98: Dual - Lumen Implantable Port Market Growth, by Injection Type, US, 2008 - 2013
• Exhibit 99: Dual - Lumen Implantable Port Market, by Injection Type, as a % of Total, US, 2007 - 2013
• Exhibit 100: Drivers of the Implantable Port Market, US
• Exhibit 101: Drivers of the Implantable Port Market, US (Cont' d)
• Exhibit 102: Limiters of the Implantable Port Market, US
• Exhibit 103: Leading Competitors in the Implantable Port Market, as a % of Total, US, 2008

CHAPTER 6: DIALYSIS CATHETER MARKET

• Exhibit 104: Dialysis Catheter Market, US (US$), 2007 - 2013
• Exhibit 105: Incidence and Prevalence of ESRD, US, 2007 - 2013
• Exhibit 106: Incident ESRD Cases, by Initial Mode of Therapy, US, 2007 - 2013
• Exhibit 107: Treatment of ESRD in the Incident Population, by Type, US, 2007 - 2013
• Exhibit 108: Treatment of ESRD in the Prevalent Population, by Type, US, 2007 - 2013
• Exhibit 109: Incident ESRD Hemodialysis Cases, by Initial Mode of Vascular Access, US, 2007 - 2013
• Exhibit 110: Incident ESRD Hemodialysis Cases, by Mode of Vascular Access after 90 Days, US, 2007 - 2013
• Exhibit 111: Prevalent ESRD Hemodialysis Cases, by Mode of Vascular Access, US, 2007 - 2013
• Exhibit 112: Treatment Algorithm for Incident ESRD, 2008
• Exhibit 113: Treatment Algorithm for Prevalent ESRD, 2008
• Exhibit 114: Dialysis Catheter Procedures, by Catheter Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 115: Dialysis Catheter Procedures, by Catheter Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 116: Dialysis Catheter Procedures, by Catheter Coating, US, 2007 - 2013 (Graphical Format)
• Exhibit 117: Acute Dialysis Catheter Procedures, by Coating, US, 2007 - 2013 (Tabular Format)
• Exhibit 118: Dialysis Catheter Market, by Catheter Type, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 119: Dialysis Catheter Market, by Catheter Type, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 120: Dialysis Catheter Market Growth, by Catheter Type, US, 2008 - 2013
• Exhibit 121: Dialysis Catheter Market, by Catheter Type, as a % of Total, US, 2007 - 2013
• Exhibit 122: Acute Dialysis Catheter Market, by Coating, US, 2007 - 2013 (Graphical Format)
• Exhibit 123: Acute Dialysis Catheter Market, by Coating, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 124: Acute Dialysis Catheter Market Growth, by Coating, US, 2008 - 2013
• Exhibit 125: Acute Dialysis Catheter Market, by Coating, as a % of Total, US, 2007 - 2013
• Exhibit 126: Drivers of the Dialysis Catheter Market, US
• Exhibit 127: Limiters of the Dialysis Catheter Market, US
• Exhibit 128: Leading Competitors in the Dialysis Market, by Catheter Type, as a % of Total, US, 2008

CHAPSTER 7: HUBER NEEDLE MARKET

• Exhibit 129: Huber Needle Market, US (US$), 2007 - 2013
• Exhibit 130: Huber Needle Sales, by Type, US, 2007 - 2013 (Graphical Format)
• Exhibit 131: Huber Needle Sales as a Function of Chemotherapy Treatment Cycles, US, 2007 - 2013
• Exhibit 132: Huber Needle Sales, by Type, US, 2007 - 2013 (Tabular Format)
• Exhibit 133: Safety Huber Needle Sales, by Injection Type, US, 2007 - 2013
• Exhibit 134: Huber Needle Market, by Type, US (US$), 2007 - 2013 (Graphical Format)
• Exhibit 135: Huber Needle Market, by Type, US (US$), 2007 - 2013 (Tabular Format)
• Exhibit 136: Huber Needle Market Growth, by Type, US, 2008 - 2013
• Exhibit 137: Huber Needle Market, by Type, as a % of Total, US, 2007 - 2013
• Exhibit 138: Safety Huber Needle Market, by Injection Type, US (US$), 2007 - 2013
• Exhibit 139: Safety Huber Needle Market Growth, by Injection Type, US, 2008 - 2013
• Exhibit 140: Safety Huber Needle Market, by Injection Type, as a % of Total, US, 2007 - 2013
• Exhibit 141: Drivers of the Huber Needle Market, US
• Exhibit 142: Limiters of the Huber Needle Market, US
• Exhibit 143: Leading Competitors in the Huber Needle Market, as a % of Total, US, 2008

APPENDIX B: SUPPLEMENTAL EXHIBITS

• Exhibit 144: Vascular Access Device Market, US (US$), 2007 - 2013
• Exhibit 145: Vascular Access Device Market, by Type, as a % of Total, US, 2008
• Exhibit 146: Short PIVC Market, by Setting, US (US$), 2007 - 2013
• Exhibit 147: Acute CVC Procedures, by Coating, US, 2007 - 2013
• Exhibit 148: PICC Sales, by Injection Type, US, 2007 - 2013
• Exhibit 149: Implantable Port Procedures, by Lumen Number, US, 2007 - 2013
• Exhibit 150: Chronic Dialysis Catheter Market, US (US$), 2007 - 2013
• Exhibit 151: Huber Needle Sales, by Type, US, 2007 - 2013